Diathermy On Diabetes Glucose Monitoring Effectiveness

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age4+
SponsorUniversity of Nottingham

About this trial

The goal of this observational study is to investigate if diathermy (a surgical tool that uses electrical energy to control bleeding) has any affect on the accuracy and functioning of continuous glucose monitoring systems in adults and young people with Type 1 Diabetes. The main questions this study aims to answer is -

\- Does the accuracy of continuous glucose monitoring systems change after use of diathermy?

Participants will:

* Have their height and weight checked. * Provide information about their medical history including type of diabetes, other medical conditions and any current medications they take. * Have paired glucose meter and sensor glucose measurements taken every 15-75 minutes from up to 4 hours before surgery until up to 4 hours after the end of surgery. * Have two blood samples taken to measure glucose levels, The first one will be before the use of diathermy and the second will be after the use of diathermy.

Eligibility criteria

Qualifiers

Diagnosis of type 1 diabetes mellitus.

Planned admission for elective surgery at Nottingham University Hospitals NHS Trust.

Currently routinely using a prescribed Abbott Libre-2, Abbott Libre-3, Dexcom G6 or Dexcom G7 glucose monitoring system to monitor glucose concentrations.

Aged 4 years or older on the day of surgery.

Disqualifiers

Use of paracetamol above maximum dose within 7 days before the scheduled date of surgery (in adults with body weight under 51kg - maximum of 60mg/kg per day, in adults with body weight 51kg and above - maximum of 4g per day, in children - maximum dose as per their age as stated in the British National Formulary for Children)

Any use of hydroxyurea within 7 days before the scheduled date of surgery

Use of more than 500mg per day of ascorbic acid / vitamin C within 7 days before the scheduled date of surgery

Currently taking medications as part of a clinical trial.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

126 Participants
are grouped into 1 trial group

Sponsors and collaborators